Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Nevada
Susan G. KomenLawmakers in Nevada passed and Gov. Joe Lombardo signed legislation into law that removes out-of-pocket costs for diagnostic and supplemental imaging.
Lawmakers in Nevada passed and Gov. Joe Lombardo signed legislation into law that removes out-of-pocket costs for diagnostic and supplemental imaging.
For decades, people struggling with infertility had to add social stigma to problems. A Penn State Health doctor discusses the causes and treatments of infertility and how attitudes have shifted.
The Endocrine Society selected Dalal S. Ali, M.D., as the recipient of its 2023 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and research contributions related to bone disease, calcium and endocrine disorders in pregnancy.
The University of Chicago Medicine opened its first women’s health clinic in Chicago’s northern suburbs as the Hyde Park-based academic health system continues to expand its primary and specialty care offerings closer to patients’ homes.
An international research team from Tanzania and Japan created a smartphone app and conducted a pilot study of how the app might be used to improve midwives’ knowledge and skills in Tanzania. Their study focused on the app’s potential effects on the learning outcomes of midwives and birth preparedness of pregnant women in Tanzania.
University of Maryland Medical Center, located in the healthcare hub city of Baltimore, receives national recognition for its academic maternal care units.
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy of palbociclib maintenance in combination with second-line endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer who had showed a confirmed progressive disease on first-line palbociclib plus endocrine therapy-based treatment after having achieved clinical benefit to this regimen.
Researchers at the Beckman Institute for Advanced Science and Technology found that early exposure to an environmental chemical called polychlorinated biphenyls, or PCBs, made it more difficult for mice to recover from sound-related trauma sustained later in life.
An observational cohort study out of Roswell Park Comprehensive Cancer Center demonstrates that race and ethnicity affect a woman’s 21-gene recurrence score, a tool used to determine risk of recurrence and distant metastasis in patients with early-stage, hormone-receptor-positive breast cancer. Based on the expression of 21 cancer-related genes detected in pre-treatment tumor specimens, recurrence score is used routinely in clinical care to identify patients who might benefit from chemotherapy as part of their treatment plan. Scores range from 0-100, with a score of 26 or higher indicating greater risk of recurrence and poorer overall survival.
Women ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today in Hypertension, a peer-reviewed American Heart Association journal.
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.
Women's gymnastics has the highest rate of preseason concussion of all NCAA sports, with women gymnasts experiencing concussions at a rate 50% higher than football players.
New research led by an international team supported by the American Cancer Society shows women with an increasing number of regular mammography screening exams prior to diagnosis of breast cancer considerably improved their probability of survival. The findings were presented at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 2-6.
MEDSIR announced today the positive results of the PHERGain trial. This study is the first to use an adaptive design that tailors treatment in the neoadjuvant/adjuvant setting of patients with HER2-positive early breast cancer. The main objective of this trial was to assess the feasibility of a chemotherapy-free strategy based on a dual HER2 blockade with trastuzumab and pertuzumab through a positron emission tomography (PET)-based, pathologic complete response response(pCR)-adapted strategy.
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone therapy there are significant survival benefits for patients with early hormone-receptor (HR) positive/HER2 negative breast cancer.
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
As pesquisas sobre dissecção espontânea de artéria coronária aumentaram muito na última década, diz a Dra. Sharonne N. Hayes, cardiologista da Mayo Clinic e especialista principal nessa doença cardíaca rara.
La investigación sobre la disección espontánea de la arteria coronaria se ha disparado en la última década, dice la Dra. Sharonne N. Hayes, cardióloga en Mayo Clinic y experta destacada de esta afección cardíaca poco frecuente.
لقد كثرت الأبحاث في العقد الماضي حول التسلخ التلقائي للشريان التاجي، وتقول الدكتورة شارون إن. هايز، طبيبة القلب في مايو كلينك، وخبيرة رائدة في حالة القلب النادرة هذه.
Read about new melanoma treatment practices, how models provide information about a rare adrenal cancer, a potential oral medication for brain cancer, and clinical trials for cancer patients with HIV.
Todo lo que los médicos e investigadores saben acerca de la medicina, desde qué medicamentos recetar hasta cómo realizar las cirugías, se basa en la investigación. Pero durante décadas, la mayor parte de este trabajo ha dejado de lado a las participantes femeninas.
As part of a continued focus on making cancer screenings more accessible to the greater Philadelphia community, Penn Medicine is providing free cancer screenings, no insurance required, including advanced 3D mammograms, in West Philadelphia this June.
A new study from the University of Bergen reveals that including offspring birthweight information from women’s subsequent births, is helpful in identifying a woman's long-term risk of dying from cardiovascular causes.
The COVID-19 pandemic has had a significant impact on Indigenous individuals during pregnancy and the postpartum (perinatal) period.
A new study led by researchers from the University of Sydney has found young women’s engagement with social media plays a major role in shaping how they think – and act – in relation to their health.
A clinical trial, led by Dana-Farber Cancer Institute, has shown that a telephone-based weight loss program can help patients with breast cancer whose body mass index is in the overweight or obese range lower their weight by a meaningful degree.
Breast cancer treatments that can save a woman’s life can seriously harm her sexual health. Although doctors have not historically been prepared to help patients manage these toxic side effects, Dr. Kristin Rojas at Sylvester Comprehensive Cancer Center has created a program to address women’s sexual health after cancer treatment.
Susan G. Komen thanked lawmakers in Minnesota for passing and Gov. Tim Walz for signing legislation that eliminates out-of-pocket costs for diagnostic and supplemental breast imaging.
Medicaid must be part of any solution to address the current maternal mortality crisis and racial inequities in the United States, according to a new analysis by researchers at the George Washington University.
Depression is considered the most common complication of childbirth, and new mothers shouldn’t feel ashamed or embarrassed about seeking mental health care and treatments including therapy and medication, advised experts at UT Southwestern Medical Center.
Ann Chuang, M.D., a highly skilled breast surgeon, has been appointed as the leader of Hackensack Meridian Mountainside Medical Center's breast program.
Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes.
Investigators from the Smidt Heart Institute at Cedars-Sinai found that women who experience an adverse pregnancy outcome—such as gestational hypertension, preeclampsia or preterm birth—have a higher risk of developing stroke in their lifetime, and at a younger age.
From humans to plants to single-cell organisms, there’s a protein that rules them all. This protein does general housekeeping of the cells, regulating them through normal daily functions. Virginia Tech researchers found that one specific form of this ubiquitous protein has a different function in the female brains – it helps regulate events in the memory that cause post-traumatic stress disorder (PTSD).
The commonly used U.S version of the Fracture Risk Assessment Tool (FRAX) should not be routinely used to select younger postmenopausal women for bone mineral density testing. But the Osteoporosis Self-Assessment Tool (OST) is excellent at identifying women with osteoporosis-level bone mineral density, which is the goal of these screenings, while FRAX is not.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent COVID-19 booster vaccinations administered in early pregnancy (before 20 weeks’ gestation) were not associated with miscarriage. The research adds to the growing understanding about the safety of COVID-19 booster vaccinations among people who are pregnant.
Every year, more than 40,000 women die of ovarian cancer in Europe. Ovarian cancer is a genetically very heterogeneous disease, which makes it exceptionally difficult to study and treat.
In this case-control surveillance study of more than 100,000 pregnancies, COVID-19 booster vaccination in pregnancy was not associated with spontaneous abortion. These findings support the safety of recommendations for COVID-19 booster vaccination, including in pregnant populations.
Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.
The Uniformed Services University (USU) has been awarded a $404,703 grant to implement a WIC Community Innovation and Outreach Project (WIC CIAO), designed to increase WIC enrollment in active duty military families.
A new study suggests that increasing rates of induction of labour (IOL) of pregnant women and people in the UK, without considering the accompanying, real-world impact on staffing workloads and patient care, may have unintended consequences.
Mount Sinai doctors and students will share new insights on prenatal care